Chapter 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET– By Disease Type

6.1. Systemic Autoimmune Disease

       6.1.1. Rheumatoid Arthritis

       6.1.2. Psoriasis

       6.1.3. Systemic Lupus Erythematosus (SLE)

       6.1.4. Multiple Sclerosis

       6.1.5. Other Systemic Autoimmune Diseases

6.2. Localized Autoimmune Disease

       6.2.1. Inflammatory Bowel Disease

       6.2.2. Type 1 Diabetes

       6.2.3. Thyroid

       6.2.4. Other Localized Autoimmune Diseases

Chapter 7. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET– By Diagnosis

7.1. Antinuclear Antibody Tests

7.2. Autoantibody Tests

7.3. Complete Blood Count (CBC)

7.4. C-reactive Protein (CRP)

7.5. Urinalysis

7.6. Others tests

Chapter 8. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET– By Region

8.1. North America

8.2. Europe

8.3. The Asia Pacific

8.4. Latin America

8.5. Middle-East and Africa

Chapter 9. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

9.1. Company 1

9.2. Company 2

9.3. Company 3

9.4. Company 4

9.5. Company 5

9.6. Company 6

9.7. Company 7

9.8. Company 8

9.9. Company 9

9.10. Company 10